In this context, FOXK2-mediated cytotoxic effects in breast cancer cells have been demonstrated to be stimulated by SUMOylation (Figure 5), in a study which identified two consensus SUMOylation motifs within the FOXK2 sequence [51]. The gene discussed is FOXK2; the disease is breast carcinoma.